Breaking News on Pharmaceutical Technology

NJ pharma employment down in ‘08

22-Jun-2009 - The number of pharma employees in New Jersey, US fell by 1,400 in 2008, with R&D expenditure, capital investment and product trials also declining, according to a report.

Bio drugs to dominate top ten list by 2014

18-Jun-2009 - Seven of the top ten drugs will be biopharmaceuticals by 2014 according to sector analysts Evaluate Pharma.

Watson to acquire Arrow for $1.75bn

18-Jun-2009 - Watson Pharmaceuticals is to acquire Arrow Group for $1.75bn (€1.26bn), adding to the company’s manufacturing network and providing it with the expertise needed to enter the biogenerics market.

Mega deals not ‘mega’ for Big Pharma R&D long term, says F&S

17-Jun-2009 - As rumours of a failed Sanofi Aventis’ bid for a US rival circulate, F&S’ analysis of M&As is well timed, even if its conclusions will be difficult reading for a Big Pharma sector set on replenishing pipelines via big deals.

Pharma: people on the move

17-Jun-2009 - in-PharmaTechnologist presents its latest round up of appointments in the pharmaceutical sector, including a former mayor joining Eli Lilly and new CEOs at three companies.

Lonza’s GS system wins Elusys anthrax Ab contract

16-Jun-2009 - Swiss life sciences solutions firm Lonza has been contracted by US biotechnology group Elusys Therapeutics to produce Anthim, its late stage Ab candidate treatment for anthrax infection.

GAVI’s AMC hopes to stimulate vaccine dev

16-Jun-2009 - The GAVI Alliance has launched an advance market commitment (AMC), which is using a $1.5bn (€1.1bn) fund to ensure the supply of pneumococcal vaccine to developing countries at affordable prices.

Pfizer concealing reboxetine data, says IQWiG

15-Jun-2009 - Germany’s IQWiG has accused US drugmaker Pfizer of “concealing data on the effect of a drug Edronax for the treatment of depression.”

UAE makes big efforts to attract pharma

15-Jun-2009 - The United Arab Emirates (UAE) is looking to establish itself as a prime location for pharmaceutical companies, with “massive amounts of money and huge incentives” being used to attract business.

News in brief

Vaccine market predicted to double by 2013

15-Jun-2009 - The world vaccine market will more than double by 2013, according to a report by Kalorama Information, with growth driven by a strong pipeline and rising usage of current products.

FTC calls for biogenerics path and end of “pay for delay” deals

11-Jun-2009 - The US Federal Trade Commission (FTC) believes that an effective FOB approval pathway and laws preventing “pay-for-delay” deals are the only ways of reducing the cost of biologic drugs.

News in brief

Spanish Police say seized Viagra pills made in China and India

11-Jun-2009 - The 9,000 counterfeit Viagra tablets seized by Spanish police earlier this week at three properties in Alicante were imported from India and China, according to various media reports.

GSK grows in Asia vacc market

10-Jun-2009 - UK drug major GSK has had a busy week in the Asia, signing an influenza vaccine manufacturing deal with China’s Shenzhen Neptunus Interlong Bio-Technique just days after it opened a new S$600m (EUR294m) production facility in Singapore.

Sanofi swoops for Pfizer insulin plant, scuppering MannKind's bid

09-Jun-2009 - Sanofi Aventis will pay Pfizer €30m ($41m) for a former Exubera manufacturing plant in Frankfurt-Höchst, Germany that was due to be bought by inhaled insulin specialist MannKind.

Pharma: people on the move

09-Jun-2009 - in-PharmaTechnologist presents its latest round up of appointments in the pharmaceutical sector, including media reports of a new CEO at Proctor & Gamble.

News in brief

Big Pharma greener than most

09-Jun-2009 - Big Pharma has performed well in Climate Counts’ survey of companies’ environmental measures, with most regarded as having made good efforts but Wyeth and Amgen lagged behind.

News in brief

Mylan calls for end of generic exclusivity “abuse”

04-Jun-2009 - Heather Bresch, Mylan’s chief operating officer, has called for an end of the “abuse” of the 180 day generic exclusivity period by brand manufactures that launch a competitor during this period.

Meet Our New Owners

03-Jun-2009 - Don’t miss this video interview with Robert Marr, chief operating officer of William Reed Business Media which recently acquired Decision News Media publisher of in-PharmaTechnologist.

News in brief

FDA transparency committee set up under Obama openness pledge

03-Jun-2009 - New US FDA Commissioner Margaret Hamburg has created a transparency taskforce to better explain the agency’s decision making processes.

in-PharmaTechnologist.com acquired by William Reed Business Media

01-Jun-2009 - Decision News Media, publisher of in-PharmaTechnologist.com, outsourcing-pharma.com and 15 other websites serving the international food, nutrition, pharmaceutical and cosmetics industries, has been acquired by the leading UK business-to-business publisher William Reed Business Media.

News in brief

GSK may move for 51% of Shantha

01-Jun-2009 - UK drug major GSK is considering a bid for a 51 per cent share of India’s Shantha Biotech after European rival Sanofi Aventis pulled out of an acquisition deal last week, according to India’s Economic Times.

Pharma: people on the move

01-Jun-2009 - in-PharmaTechnologist presents its latest round up of movements in the pharmaceutical sector, including job changes at Mylan and Elan.

UK trade office may check GSK and Pfizer HIV joint-venture

28-May-2009 - GSK and Pfizer’s HIV joint venture (JV) may be subject to an investigation by UK competition watchdog the Office of Fair Trading (OFT), according to various media reports.

Harsh counterfeiting sentences could harm LDCs

27-May-2009 - Stiffer penalties for counterfeiters could be counterproductive in less developed countries (LDC) and “entrench the corrupt symbiotic relationship between counterfeiters, lawmakers and officials”, according to a report